{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:58:44Z","timestamp":1794009524896,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ80820"],"award-info":[{"award-number":["2025JJ80820"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82405362"],"award-info":[{"award-number":["82405362"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.colsurfb.2026.115616","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:05:38Z","timestamp":1773421538000},"page":"115616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["cRGD-modified, pH-sensitive liposomes for co-delivery of docetaxel and ABCG2 siRNA enhance therapeutic efficacy in triple-negative breast cancer"],"prefix":"10.1016","volume":"264","author":[{"given":"Ying","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nengbin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2026.115616_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.colsurfb.2026.115616_bib2","first-page":"3865","article-title":"Leukocyte\/platelet hybrid membrane-camouflaged dendritic large pore mesoporous silica nanoparticles co-loaded with photo\/chemotherapeutic agents for triple negative breast cancer combination treatment","volume":"6","author":"Zhang","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.colsurfb.2026.115616_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.10.012","article-title":"Metabolic-pathway-based subtyping of triple-negative breast cancer reveals potential therapeutic targets","volume":"33","author":"Gong","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.colsurfb.2026.115616_bib4","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/annonc\/mdy127","article-title":"Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis","volume":"29","author":"Poggio","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.colsurfb.2026.115616_bib5","article-title":"Neoadjuvant treatment for triple negative breast cancer: recent progresses and challenges","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2026.115616_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cells8090957","article-title":"Mechanisms of chemotherapy resistance in triple-negative breast cancer-how we can rise to the challenge","volume":"8","author":"Nedeljkovic","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.colsurfb.2026.115616_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031665","article-title":"Molecular mechanisms, biomarkers and emerging therapies for chemotherapy resistant TNBC","volume":"23","author":"Ferrari","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2026.115616_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12033-009-9220-6","article-title":"Pharmacogenetics of membrane transporters: an update on current approaches","volume":"44","author":"Sissung","year":"2010","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.colsurfb.2026.115616_bib9","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s10549-012-2398-5","article-title":"High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival","volume":"137","author":"Yamada","year":"2013","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.colsurfb.2026.115616_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082365","article-title":"Clinical Significance of ABCG2\/BCRP quantified by fluorescent nanoparticles in breast cancer patients undergoing neoadjuvant chemotherapy","volume":"15","author":"Tada","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.colsurfb.2026.115616_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-018-0197-8","article-title":"Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2","volume":"51","author":"Arumugam","year":"2019","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.colsurfb.2026.115616_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-015-0362-9","article-title":"FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance","volume":"14","author":"Westover","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.colsurfb.2026.115616_bib13","first-page":"1765","article-title":"FL118, a novel camptothecin analogue, overcomes irinotecan and topotecan resistance in human tumor xenograft models","volume":"7","author":"Ling","year":"2015","journal-title":"Am. J. Transl. Res"},{"key":"10.1016\/j.colsurfb.2026.115616_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-023-00981-9","article-title":"Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges","volume":"30","author":"Kang","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.colsurfb.2026.115616_bib15","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.2147\/IJN.S436038","article-title":"A Comprehensive review of small interfering RNAs (siRNAs): mechanism, therapeutic targets, and delivery strategies for cancer therapy","volume":"18","author":"Zhang","year":"2023","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.colsurfb.2026.115616_bib16","doi-asserted-by":"crossref","first-page":"11527","DOI":"10.1021\/acs.chemrev.0c00997","article-title":"Polymeric Delivery of Therapeutic Nucleic Acids","volume":"121","author":"Kumar","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.colsurfb.2026.115616_bib17","doi-asserted-by":"crossref","first-page":"12181","DOI":"10.1021\/acs.chemrev.1c00244","article-title":"Lipids and Lipid Derivatives for RNA Delivery","volume":"121","author":"Zhang","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.colsurfb.2026.115616_bib18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and Challenges of Liposome Assisted Drug Delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front Pharm."},{"key":"10.1016\/j.colsurfb.2026.115616_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2026.115616_bib20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.omtm.2020.07.015","article-title":"Barriers and strategies of cationic liposomes for cancer gene therapy","volume":"18","author":"Liu","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.colsurfb.2026.115616_bib21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2015.08.017","article-title":"Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors","volume":"219","author":"Miao","year":"2015","journal-title":"J. Control Release"},{"key":"10.1016\/j.colsurfb.2026.115616_bib22","article-title":"Microfluidic-assisted synthesis of integrin-targeting cRGD liposomes as a scalable strategy for theranostic applications in triple-negative breast cancer","volume":"213","author":"Ovejero-Paredes","year":"2025","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2026.115616_bib23","doi-asserted-by":"crossref","first-page":"56676","DOI":"10.1021\/acsami.4c10812","article-title":"cRGD-Peptide modified covalent organic frameworks for precision chemotherapy in triple-negative breast cancer","volume":"16","author":"Benyettou","year":"2024","journal-title":"ACS Appl. Mater. & Interfaces"},{"key":"10.1016\/j.colsurfb.2026.115616_bib24","article-title":"Enhanced anti-tumor efficacy and tumor accumulation of Tamoxifen through cRGD functionalized cholesterol based lipopolymeric nanoparticles for targeted breast cancer therapy","volume":"90","author":"Mazumdar","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.colsurfb.2026.115616_bib25","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1039\/D4TB02083A","article-title":"Mechanistic understanding of pH as a driving force in cancer therapeutics","volume":"13","author":"Pandey","year":"2025","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.colsurfb.2026.115616_bib26","doi-asserted-by":"crossref","first-page":"26882","DOI":"10.1021\/acsami.8b07425","article-title":"Tumoral Acidic pH-Responsive cis-Diaminodichloroplatinum-Incorporated Cy5.5-PEG- g-A-HA nanoparticles for targeting delivery of cddp against cervical cancer","volume":"10","author":"Cheng","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.colsurfb.2026.115616_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-020-00604-7","article-title":"Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells","volume":"18","author":"da Rocha","year":"2020","journal-title":"J. nanobiotechnology"},{"key":"10.1016\/j.colsurfb.2026.115616_bib28","doi-asserted-by":"crossref","first-page":"43779","DOI":"10.18632\/oncotarget.6085","article-title":"Enhanced therapeutic effect of Adriamycin on multidrug resistant breast cancer by the ABCG2-siRNA loaded polymeric nanoparticles assisted with ultrasound","volume":"6","author":"Bai","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.colsurfb.2026.115616_bib29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2014.09.001","article-title":"Nanocarrier mediated delivery of siRNA\/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances","volume":"194","author":"Gandhi","year":"2014","journal-title":"J. Control Release"},{"key":"10.1016\/j.colsurfb.2026.115616_bib30","article-title":"Nanoparticle drug delivery systems for synergistic delivery of tumor therapy","volume":"14","author":"Chen","year":"2023","journal-title":"Front Pharm."},{"key":"10.1016\/j.colsurfb.2026.115616_bib31","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.2147\/IJN.S129574","article-title":"Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system","volume":"12","author":"Xiang","year":"2017","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.colsurfb.2026.115616_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116781","article-title":"Chitosan based pH-responsive polymeric prodrug vector for enhanced tumor targeted co-delivery of doxorubicin and siRNA","volume":"250","author":"Yan","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.colsurfb.2026.115616_bib33","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.2174\/1381612824666180807121935","article-title":"Targeted Liposomes for siRNA Delivery to Cancer","volume":"24","author":"Eloy","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.colsurfb.2026.115616_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","article-title":"Nanomedicine in cancer therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.colsurfb.2026.115616_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176914","article-title":"Targeting overexpressed surface proteins: A new strategy to manage the recalcitrant triple-negative breast cancer","volume":"981","author":"Raj","year":"2024","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.colsurfb.2026.115616_bib36","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1021\/mp3002733","article-title":"RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis","volume":"9","author":"Danhier","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2026.115616_bib37","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-021-00904-6","article-title":"The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1\/P-STAT3\/VEGFA axis in triple-negative breast cancer","volume":"19","author":"Gong","year":"2021","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.colsurfb.2026.115616_bib38","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1039\/D2NH00590E","article-title":"cRGD-modified nanoparticles of multi-bioactive agent conjugate with pH-sensitive linkers and PD-L1 antagonist for integrative collaborative treatment of breast cancer","volume":"8","author":"Zou","year":"2023","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.colsurfb.2026.115616_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0197-8","article-title":"Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2","volume":"51","author":"Arumugam","year":"2019","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.colsurfb.2026.115616_bib40","first-page":"2473","article-title":"Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs","volume":"7","author":"Li","year":"2012","journal-title":"Int. J. Nanomed."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526002043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526002043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:55:21Z","timestamp":1779105321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776526002043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":40,"alternative-id":["S0927776526002043"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115616","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"cRGD-modified, pH-sensitive liposomes for co-delivery of docetaxel and ABCG2 siRNA enhance therapeutic efficacy in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115616","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115616"}}